• Your shopping cart is empty!

  • CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute, 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/03/2017

Pages:70

File Size:1 file , 2.9 MB

Note:This product is unavailable in Russia, Belarus

This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More CLSI standard pdf

CLSI AUTO04-A

CLSI AUTO04-A

Laboratory Automation: Systems Operational Requirements, Characteristics, and Information Elements; Approved Standard, AUTO04AE

$107.00 $214.51

CLSI AUTO05-A

CLSI AUTO05-A

Laboratory Automation: Electromechanical Interfaces; Approved Standard, AUTO05AE

$125.00 $250.90

CLSI AUTO3A

CLSI AUTO3A

Laboratory Automation: Communications with Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems; Approved Standard, AUTO3-A

$107.00 $215.38

CLSI AUTO01-A

CLSI AUTO01-A

Laboratory Automation: Specimen Container/Specimen Carrier; Approved Standard, AUTO01AE

$90.00 $180.00